Pamorelin la 3.75mg injection

Injection of Pamorelin LA 3.75mg contains Triptorelin Pamoate, which is a Gonadotropin-releasing hormone (GnRH) agonist to treat advanced prostate cancer. It likewise inhibits testosterone levels, a hormone responsible for the enlargement of prostate cancer cells.

Pamorelin LA is administered as a long-acting intramuscular injection by a medical professional, typically once every four weeks. By reducing hormone levels, Pamorelin LA works to slow cancer growth and relieve associated symptoms, such as bone pain and urinary symptoms. 

All oncology formulations manufactured by Rizochem Pharmaceuticals are globally distributed for sale in international markets and comply with both WHO-GMP and ISO standards. All products are genuine, effective, and safe.

• Regulates prostate cancer cell growth 
• Provides pain and urinary symptoms relief 
• Long-acting monthly administration for ease of use 
• An important part of hormonal therapy for prostate cancer 
• Manufactured and supplied through a registered exporter 

 Side effects may include:

•   Hot flashes
•   Pain or redness at the site of injection
•   Mild bone or joint pain
•   Headaches or dizziness
•   Fatigue or depression in the short term

Seek medical care for the following symptoms: severe allergic reaction, difficulty breathing, or pain does not go away.

With over 10 years of global pharmaceutical export experience, Rizochem Pharmaceuticals delivers authentic oncology medicines from WHO-GMP-approved manufacturing facilities.
We export to more than 15 countries, including the UAE, Oman, Qatar, Saudi Arabia, Netherlands, Myanmar, Albania, and South Africa, ensuring competitive pricing, cold-chain shipment, and on-time delivery.

It is used to treat advanced prostate cancer in men, by lowering testosterone.

Pamorelin LA injection is given as an intramuscular injection, once every four weeks under a doctor’s supervision. Depending on the doctor’s instructions, the agent may be absorbed sooner.

Mild bone pain can occur as a symptom of the response in the early stages of treatment, but this will improve after a few weeks.

No, the injection can only be administered by a must be given by a qualified health care professional.

Yes, Rizochem Pharmaceuticals exports Triptorelin-based injections internationally at wholesale rates.

Explore other oncology medicines like Leuprolide 3.75mg Injection, Degarelix 80mg Injection, and Goserelin 3.6mg Injection